Status
ACTIVE
Global HQ
Tokyo, Japan
Countries of investment
- Japan
Investment stages
- Series B
- Series C
Industries
- Fintech
- Blockchain
- Cryptocurrency
- AI
- Data Science
About
Docor Docor International B.V. is a leading global provider of innovative healthcare solutions and advanced medical devices, dedicated to enhancing patient outcomes across various clinical settings. As a proud subsidiary of Crecor B.V., Docor leverages state-of-the-art technologies and research-driven methodologies to develop groundbreaking products that address the evolving needs of the healthcare industry. With a commitment to excellence and a focus on patient-centric solutions, Docor aims to set new standards in medical care and positively impact the lives of patients worldwide.
Docor Docor International B.V. is a leading global provider of innovative healthcare solutions and advanced medical devices, dedicated to enhancing patient outcomes across various clinical settings. As a proud subsidiary of Crecor B.V., Docor leverages state-of-the-art technologies and research-driven methodologies to develop groundbreaking products that address the evolving needs of the healthcare industry. With a commitment to excellence and a focus on patient-centric solutions, Docor aims to set new standards in medical care and positively impact the lives of patients worldwide.
Investment Thesis
Docor International Management focuses on investments in early to growth stage companies with a strong emphasis on innovative technologies and life sciences. Their investment thesis centers on identifying businesses with scalable models, strong leadership, and the potential to make a substantial impact on their industries, particularly in healthcare, biotechnology, and technology sectors.
Manager's Experience
With a robust background in private equity, the fund manager has built a diversified portfolio primarily in technology and healthcare sectors across North America and Europe. Having executed over 30 successful deals, they emphasize a data-driven investment strategy that prioritizes early to growth-stage opportunities. Notable exits include influential companies positioned at the forefront of innovation, demonstrating a keen ability to identify market trends. Their operator-first approach fosters strong partnerships, ensuring sustainable value creation throughout the investment lifecycle.
Docor Contacts Information
Secondary contact
Team
Miriam Pinchasow
Alon Dumanis
Adi Goldin